High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report. JAMA Neurol. 2014.
Immune surveillance of the central nervous system in multiple sclerosis - Relevance for therapy and experimental models. J Neuroimmunol. 2014..
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects. Curr Treat Options Neurol. 2013..